Morgan Stanley 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 12:29 pm Sale | 2024-01-31 | 13G | Mirati Therapeutics, Inc. MRTX | MORGAN STANLEY MS | 0 0.000% | -6,079,302 (Position Closed) | Filing |
| 2024-02-09 12:20 pm Purchase | 2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | MORGAN STANLEY MS | 6,079,302 8.700% | 6,079,302 (New Position) | Filing |